Augusto SpA, majority shareholder of Aedes Sisiq, had given the assignment to Rothchild & Co Italy last year, as external advisor, for the sale of the entire investment in Aedes SIIQ, equal to 51.25%. As a part of the mandate, Rothchild & Co Italy had to take care, among other things, of the selection process...Read More